Loading...
ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer worldwide, and the 5-year survival rates are among the worst of the major cancers. Oncolytic herpes simplex viruses (oHSV) have the potential to make a significant impact in the targeted treatment of these patients. Here...
Na minha lista:
| Udgivet i: | Mol Ther Oncolytics |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4782961/ https://ncbi.nlm.nih.gov/pubmed/27119105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2015.8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|